2cureX publishes interim report for the first quarter of 2020
2cureX AB (“2cureX”) hereby publishes the interim report for the first quarter of 2020. The interim report is available as an attached document as well as on the company’s website (www.2curex.com). Below follows a short summary of the report.CEO Ole Thastrup comments “2cureX continues to execute on the business objectives necessary for a successful launch of the IndiTreat test in second half of 2020. Commercial partnerships with regional distributors and hospitals are key components of our launch strategy. In this quarter we established a commercial presence in Europe by signing